Sulfur-substituted hemicyanine nanosensors enable noninvasive evaluation of diabetic liver dysfunction through cysteine detection
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Sulfur Compounds in Biology · Adenosine and Purinergic Signaling · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. Preventing diabetes mellitus in developing countries10.1038/nrendo.2012.46 ↗
2. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications10.1177/2047487319878371 ↗
3. Global and regional estimates and projections of diabetes-related health expenditure: results from the international diabetes federation diabetes atlas, 9th edition10.1016/j.diabres.2020.108072 ↗
4. Global trend analysis of diabetes mellitus incidence, mortality, and mortality-to-incidence ratio from 1990 to 201910.1038/s41598-023-49249-0 ↗
5. Global variability in diabetes mellitus and its association with body weight and primary healthcare support in 49 low- and middle-income developing countries10.1111/j.1464-5491.2011.03549.x ↗
6. Implementation of a liver health check in people with type 2 diabetes10.1016/S2468-1253(23)00270-4 ↗
7. Screening for advanced liver fibrosis due to metabolic dysfunction-associated steatotic liver disease alongside retina scanning in people with type 2 diabetes: a cross-sectional study10.1016/S2468-1253(24)00313-3 ↗
8. The liver as an endocrine organ-linking nafld and insulin resistance10.1210/er.2019-00034 ↗
9. Metabolic dysfunction-associated steatotic liver disease (masld) in people with diabetes: the need for screening and early intervention. A consensus report of the American diabetes association10.2337/dci24-0094 ↗
10. Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: a prospective multicenter study
11. Metabolic liver disease in diabetes - from mechanisms to clinical trials
12. The clustering of cardiovascular, renal, adipo-metabolic eye and liver disease with type 2 diabetes10.1016/j.metabol.2021.154961 ↗
13. Start small, think big: micrornas in diabetes mellitus and relevant cardiorenal-liver metabolic health spectrum10.1016/j.metabol.2025.156153 ↗
14. Oxidative stress and inflammation in hepatic diseases: current and future therapy10.1155/2017/3140673 ↗
15. Oxidative stress in liver pathophysiology and disease
16. Hepatic glucose and lipid metabolism10.1007/s00125-016-3940-5 ↗
17. The evaluation of thiol/disulphide homeostasis in diabetic nephropathy10.1016/j.diabres.2019.01.022 ↗
18. Beyond glucose: the crucial role of redox signaling in β-cell metabolic adaptation10.1016/j.metabol.2024.156027 ↗
19. A comprehensive review on the significance of cysteine in various metabolic disorders; particularly CVD, diabetes, renal dysfunction, and ischemic stroke10.2174/0113892037287215240424090908 ↗
20. Red and near-infrared fluorescent probe for distinguishing cysteine and homocysteine through single-wavelength excitation with distinctly dual emissions10.1021/acs.analchem.1c04895 ↗
21. Regulating sensing patterns in fluorescent probes for discriminative detection of biothiols10.1021/acs.analchem.4c04523 ↗
22. A fast dual-responsive off-on fluorescent probe for cysteine and glutathione without interference from homocysteine10.2116/analsci.21P088 ↗
23. Diabetes at a glance: assessing ai strategies for early diabetes detection and intervention10.58496/MJAIH/2023/017 ↗
24. An effective deep learning model for surface-enhanced raman spectroscopy detection using artificial neural network10.58496/BJML/2023/007 ↗
25. Clinical data analysis using machine learning algorithms to predict the progression of type 2 diabetes10.58496/MJAIH/2025/011 ↗
26. Employing artificial intelligence methods in drug development: a new era in medicine10.58496/MJAIH/2023/010 ↗
27. Artificial intelligence detection of diabetic retinopathy: subgroup comparison of the eyeart system with ophthalmologists' dilated examinations10.1016/j.xops.2022.100228 ↗